Absolute depth of myometrial invasion in endometrial cancer is superior to the currently used cut-off value of 50%

Gynecologic Oncology

Volumn 129, Issue 2, 2013, Pages 285-291

  Geels, Y P ^a   Pijnenborg, J M A ^b   Van Den Berg Van Erp, S H M ^c   Snijders, M P M L ^c   Bulten, J ^a   Massuger, L F A G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CPRLab   (Netherlands)

^c CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

Endometrioid endometrial carcinoma; Myometrial invasion; Prediction of recurrence

Indexed keywords

ANTINEOPLASTIC AGENT; HORMONE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER INVASION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; DISEASE SPECIFIC SURVIVAL; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; MAJOR CLINICAL STUDY; MYOMETRIUM; OVARIECTOMY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SENSITIVITY AND SPECIFICITY; SEROSA; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ENDOMETRIOID; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; LOGISTIC MODELS; MIDDLE AGED; MYOMETRIUM; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; ODDS RATIO; PREDICTIVE VALUE OF TESTS; REGISTRIES; RETROSPECTIVE STUDIES; ROC CURVE; SURVIVAL ANALYSIS;

EID: 84876288299     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.02.013     Document Type: Article

References (21)

1. F. Amant, P. Moerman, P. Neven, D. Timmerman, E. Van Limbergen, and I. Vergote Endometrial cancer Lancet 366 9484 2005 491 505 [Epub 2005/08/09]
2. Y.P. Geels, J.M. Pijnenborg, S.H. van den Berg- van Erp, J. Bulten, D.W. Visscher, and S.C. Dowdy Endometrioid endometrial carcinoma with atrophic endometrium and poor prognosis Obstet Gynecol 120 5 2012 1124 1131 [Epub 2012/10/24]
3. R.J. Zaino, R.J. Kurman, K.L. Diana, and C.P. Morrow Pathologic models to predict outcome for women with endometrial adenocarcinoma: the importance of the distinction between surgical stage and clinical stage - a Gynecologic Oncology Group study Cancer 77 6 1996 1115 1121 [Epub 1996/03/15]
4. C.L. Creutzberg, W.L. van Putten, P.C. Koper, M.L. Lybeert, J.J. Jobsen, and C.C. Warlam-Rodenhuis Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma Lancet 355 9213 2000 1404 1411 [Epub 2000/05/03]
5. D.M. Larson, G.P. Connor, S.K. Broste, B.R. Krawisz, and K.K. Johnson Prognostic significance of gross myometrial invasion with endometrial cancer Obstet Gynecol 88 3 1996 394 398 [Epub 1996/09/01]
6. J. Prat Prognostic parameters of endometrial carcinoma Hum Pathol 35 6 2004 649 662 [Epub 2004/06/10]
7. S. Pecorelli Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium Int J Gynaecol Obstet 105 2 2009 103 104 [Epub 2009/04/16]
8. C.M. Quick, T. May, N.S. Horowitz, and M.R. Nucci Low-grade, low-stage endometrioid endometrial adenocarcinoma: a clinicopathologic analysis of 324 cases focusing on frequency and pattern of myoinvasion Int J Gynecol Pathol 31 4 2012 337 343 [Epub 2012/06/02]
9. A. Ali, D. Black, and R.A. Soslow Difficulties in assessing the depth of myometrial invasion in endometrial carcinoma Int J Gynecol Pathol 26 2 2007 115 123 [Epub 2007/04/07]
10. S.M. Jacques, F. Qureshi, A. Munkarah, and W.D. Lawrence Interinstitutional surgical pathology review in gynecologic oncology: II. Endometrial cancer in hysterectomy specimens Int J Gynecol Pathol 17 1 1998 42 45 [Epub 1998/02/25]
11. T. Kaku, N. Tsuruchi, N. Tsukamoto, T. Hirakawa, T. Kamura, and H. Nakano Reassessment of myometrial invasion in endometrial carcinoma Obstet Gynecol 84 6 1994 979 982 [Epub 1994/12/01]
12. J. Lindauer, J.M. Fowler, T.P. Manolitsas, L.J. Copeland, L.A. Eaton, and N.C. Ramirez Is there a prognostic difference between depth of myometrial invasion and the tumor-free distance from the uterine serosa in endometrial cancer? Gynecol Oncol 91 3 2003 547 551 [Epub 2003/12/17]
13. K.V. Schwab, D.M. O'Malley, J.M. Fowler, L.J. Copeland, and D.E. Cohn Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinoma Gynecol Oncol 112 1 2009 146 149 [Epub 2008/10/22]
14. S. Kondalsamy-Chennakesavan, S. van Vugt, K. Sanday, J. Nicklin, R. Land, and L. Perrin Evaluation of tumor-free distance and depth of myometrial invasion as prognostic factors for lymph node metastases in endometrial cancer Int J Gynecol Cancer 20 7 2010 1217 1221 [Epub 2011/04/19]
15. S. Chattopadhyay, K.A. Galaal, A. Patel, A. Fisher, A. Nayar, and P. Cross Tumour-free distance from serosa is a better prognostic indicator than depth of invasion and percentage myometrial invasion in endometrioid endometrial cancer BJOG 119 10 2012 1162 1170 [Epub 2012/07/19]
16. www.oncoline.nl 2011
17. S.G. Silverberg, G.L. Mutter, R.J. Kurman, R.A. Kubik-Huch, F. Nogales, and F.A. Tavassoli Tumors of the uterine corpus: epithelial tumors and related lesions F.A. Tavassoli, SF WHO classification of tumors: pathology and genetics of tumors of the breast and female genital organs 5th ed. 2003 World Health Organisation 221 232
18. H.L. Ellenson, B.M. Ronnett, R.A. Soslow, R.J. Zaino, and R.J. Kurman Endometrial carcinoma R.J. Kurman, B.M. Ronnett, H.L. Ellenson, Blaustein's pathology of the female genital tract 6th ed. 2011 Springer New York 393 452
19. E.J. Wilkinson Premalignant and malignant tumors of the vulva R.J. Kurman, H.L. Ellenson, B.M. Ronnett, Blaustein's pathology of the female genital tract 6th ed. 2011 Springer 56 103
20. A.K. Witkiewicz, T.C. Wright, A. RFerenczy, B.M. Ronnett, and R.J. Kurman Carcinoma and other tumors of the cervix R.J. Kurman, H.L. Ellenson, B.M. Ronnett, Blaustein's pathology of the female genital tract 6th ed. 2011 Springer 254 303
21. A. Sedlis, B.N. Bundy, M.Z. Rotman, S.S. Lentz, L.I. Muderspach, and R.J. Zaino A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study Gynecol Oncol 73 2 1999 177 183 [Epub 1999/05/18]